Dr Aoife Dillon joins Eden from another AIM-listed group, Plant Health Care where she has been the technical director for the EMEAA Region for the past three years.
Prior to that, Dillon was chief technology officer at Exosect, a formulations company focused on the targeted delivery of biological and synthetic compounds in agriculture.
At Eden, Dillon will focus on developing the product pipeline from a biology standpoint.
The company recently opened a new laboratory where Dillon will assess the efficacy and safety of new formulations and run commercial-scale trials focused on plant biology for the environment and sustainability.
Sean Smith, Eden Research’s chief executive, said Dillon "brings an impressive range of senior executive experience and the ability to engage with and influence key stakeholders in the development and commercialisation of biocontrol products."
“Her presence at our new laboratory facilities will be integral as we ramp up our in-house capabilities to develop our product pipeline," he added in a statement.